z-logo
open-access-imgOpen Access
Alfuzosin and Symptoms of Chronic Prostatitis–Chronic Pelvic Pain Syndrome
Author(s) -
J. Curtis Nickel,
John N. Krieger,
Mary McNaughtonCollins,
Rodney U. Anderson,
Michel A. Pontari,
Daniel A. Shoskes,
Mark S. Litwin,
Richard B. Alexander,
Paige White,
Richard E. Berger,
Robert B. Nadler,
Michael P. O’Leary,
Men Long Liong,
Scott I. Zeitlin,
Shan Chuai,
J. Richard Landis,
John W. Kusek,
Leroy M. Nyberg,
Anthony J. Schaeffer
Publication year - 2008
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa0803240
Subject(s) - prostatitis , alfuzosin , medicine , pelvic pain , chronic prostatitis/chronic pelvic pain syndrome , chronic pain , physical therapy , urology , surgery , prostate , lower urinary tract symptoms , cancer
In men with chronic prostatitis-chronic pelvic pain syndrome, treatment with alpha-adrenergic receptor blockers early in the course of the disorder has been reported to be effective in some, but not all, relatively small randomized trials.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom